Measuring Emotional Awareness in Patients With Schizophrenia and Schizoaffective Disorders

被引:3
|
作者
Maassen, Eva [1 ,2 ,3 ]
Buettner, Marielle [1 ,2 ,3 ]
Broecker, Anna-Lena [1 ,2 ,3 ]
Stuke, Frauke [1 ,2 ,3 ]
Bayer, Samuel [1 ,2 ,3 ,4 ]
Hadzibegovic, Jasmina [1 ,2 ,3 ]
Just, Sandra Anna [1 ,2 ,3 ]
Bertram, Gianna [1 ,2 ,3 ]
Rau, Richard [5 ]
von Haebler, Dorothea [1 ,2 ,3 ,4 ]
Lempa, Guenter [6 ]
Montag, Christiane [1 ,2 ,3 ]
机构
[1] Charite Univ Med Berlin, Dept Psychiat & Psychotherapy, Psychiat Univ Clin, St Hedwig Hosp, Berlin, Germany
[2] Humboldt Univ, Freie Univ Berlin, Berlin, Germany
[3] Berlin Inst Hlth, Berlin, Germany
[4] Psychoanalyt Univ Berlin, Berlin, Germany
[5] Univ Munster, Dept Psychol, Munster, Germany
[6] Psychotherapy Practice, Munich, Germany
来源
FRONTIERS IN PSYCHOLOGY | 2021年 / 12卷
关键词
schizophrenia; emotional awareness; affective mentalizing; theory of mind; levels of emotional awareness scale; METACOGNITION ASSESSMENT SCALE; NEGATIVE-SYNDROME-SCALE; SOCIAL COGNITION; MIND; ASSOCIATIONS; DEFICITS; RECOGNITION; ALEXITHYMIA; EMPATHY; SELF;
D O I
10.3389/fpsyg.2021.725787
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
The ability to mentalize (i.e., to form representations of mental states and processes of oneself and others) is often impaired in people with schizophrenia spectrum disorders. Emotional awareness (EA) represents one aspect of affective mentalizing and can be assessed with the Levels of Emotional Awareness Scale (LEAS), but findings regarding individuals with schizophrenia spectrum disorders are inconsistent. The present study aimed at examining the usability and convergent validity of the LEAS in a sample of N = 130 stabilized outpatients with schizophrenia or schizoaffective disorders. An adequacy rating was added to the conventional LEAS rating to account for distortions of content due to, for example, delusional thinking. Scores of the patient group were compared with those of a matched healthy control sample. Correlation with symptom clusters, a self-report measure of EA, a measure of synthetic metacognition (MAS-A-G), and an expert rating capturing EA from the psychodynamic perspective of psychic structure (OPD-LSIA) were examined. Regarding self-related emotional awareness, patients did not score lower than controls neither in terms of conventional LEAS nor in terms of adequacy. Regarding other-related emotional awareness, however, patients showed a reduced level of adequacy compared to controls whereas no such difference was found for conventional LEAS scores. Higher conventional LEAS scores were associated with fewer negative symptoms, and higher structural integration of self-perceptions measured by the OPD-LSIA. Higher adequacy of responses correlated with fewer symptoms of disorganization as well as excitement, higher scores of self-reflection on the MAS-A-G as well as self- and object-perception and internal and external communication as measured by the subscales of the OPD-LSIA. Findings suggest that the LEAS might not be sensitive enough to detect differences between mildly symptomatic patients with schizophrenia or schizoaffective disorders and healthy controls. However, LEAS ratings are still suitable to track intraindividual changes in EA over time. Observing the adequacy of patients' responses when using the LEAS may be a promising way to increase diagnostical utility and to identify patterns of formal and content-related alterations of mentalizing in this patient group. Methodological indications for future studies are discussed.
引用
收藏
页数:11
相关论文
共 50 条
  • [11] Study of the Effect of Memantine on Negative Sign in Patients with Schizophrenia and Schizoaffective Disorders
    Tavakoli-Ardakani, Maria
    Abbaspour, Hamide
    Nasab, Abdollah Farhadi
    Meibodi, Azadeh Mazaheri
    Kheradmand, Ali
    [J]. IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2018, 17 : 122 - 129
  • [12] Neuropsychological Deficits in Elderly Schizophrenia and Schizoaffective Disorders
    Morrow, J.
    Barber, B.
    Restrepo, L.
    Mucci, G.
    Golden, C.
    Buchbinder, D.
    Chang, R.
    Wang, R.
    [J]. ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2010, 25 (06) : 513 - 514
  • [13] Psychotic mood disorders explain schizophrenia; there is no schizophrenia or schizoaffective disorder
    Lake, C.
    [J]. BIPOLAR DISORDERS, 2018, 20 : 100 - 101
  • [14] Distinct facial processing in schizophrenia and schizoaffective disorders
    Chen, Yue
    Cataldo, Andrea
    Norton, Daniel J.
    Ongur, Dost
    [J]. SCHIZOPHRENIA RESEARCH, 2012, 134 (01) : 95 - 100
  • [15] Comorbidity of substance use disorders in schizophrenia, schizoaffective and bipolar disorders
    Verdoux, H
    Mury, M
    Besancon, G
    Bourgeois, M
    [J]. ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 1996, 22 (02): : 95 - 101
  • [16] Patient characteristics, symptom severity, and movement disorders in patients with schizophrenia and schizoaffective disorder
    Chouinard, G
    Bhanji, N
    Light, M
    Margolese, H
    [J]. BIOLOGICAL PSYCHIATRY, 2003, 53 (08) : 21S - 21S
  • [17] THOUGHT AND LANGUAGE DISORDERS IN YOUNG PATIENTS WITH SCHIZOPHRENIA, SCHIZOAFFECTIVE DISORDER AND BIPOLAR DISORDER
    Pantano, Telma
    Lee, Fu I.
    Curatolo, Eliana
    Martins, Camila B.
    Helio, Elki
    [J]. SCHIZOPHRENIA RESEARCH, 2012, 136 : S301 - S301
  • [18] Schizoaffective disorder merges schizophrenia and bipolar disorders as one disease - there is no schizoaffective disorder
    Lake, Charles Ray
    Hurwitz, Nathaniel
    [J]. CURRENT OPINION IN PSYCHIATRY, 2007, 20 (04) : 365 - 379
  • [19] Gender and age effects on quetiapine serum concentrations in patients with schizophrenia or schizoaffective disorders
    Dragicevic, A
    Trotzauer, D
    Hiemke, C
    Müller, MJ
    [J]. PHARMACOPSYCHIATRY, 2005, 38 (05) : 237 - 238
  • [20] Criteria for symptom remission revisited: a study of patients affected by schizophrenia and schizoaffective disorders
    Federica Pinna
    Massimo Tusconi
    Marta Bosia
    Roberto Cavallaro
    Bernardo Carpiniello
    [J]. BMC Psychiatry, 13